2Barre-Sinoussi F, Chermann JC, Rey F, et al.Isolation of a Tlymphotropic retrovirus from a patient at risk fo acquired immune deficiency syndrome (AIDS)[J].Science, 1983, 220: 868-871.
3Popovic M, Sarngadharan MG, Read E, et al. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-Ⅲ) from patienta with AIDS and pre-AIDS[J].Science, 1984, 224: 497-500.
4Gallo RC,Salahuddin SZ,Popovic M,et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-Ⅲ) from patients with AIDS and at risk for AIDS[J]. Science, 1984, 224: 500-503.
5Schupbach J,Popovic M,Gilden RV,et al.Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-Ⅲ) associated with AIDS[J]. Science, 1984, 224: 503-505.
6Sarngadharan MG, Popovic M, Bruch L, et al. Antibodies reactive with human T- lymphotropic retroviruses(HTLV-Ⅲ) in the serum of patients with AIDS[J].Science, 1984, 224: 506-508.
7Steinbrook R. The AIDS epidemic in 2004[J]. N Engl J Med, 2004, 351: 115-117.
8Skiest DJ, Chiller T, Chiller K, et al.Protease inhibitor therapy is associated with markedly prolonged time to relapse and improved survival in AIDS patients with cytomegalovirus retinitis[J]. Int J STD AIDS,2001, 12: 659-664.
9Shuler JD, Engstrom RE Jr, Holland GN.External ocular disease and anterior segment disorders associated with AIDS[J].Int Ophthalmol Clin, 1989, 29: 98-104.
10Cunninghan ET Jr,Margolis TP. Ocular manifestations of HIV infection[J]. N Engl J Med, 1998, 339: 236-244.
3Barre-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science, 1983,220:868-871.
4Popovic M, Sarngadharan MG, Read E, et al. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-Ⅲ) from patients with AIDS and pre-AIDS. Science, 1984, 224:497-500.
5Gallo RC, Salahuddin SZ, Popovic M, et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-Ⅲ) from patients with AIDS and at risk for AIDS. Science, 1984,224:500-503.
6Kestelyn PG, Cunningham ET Jr. HIV/AIDS and blindness. Bull World Health Organ, 2001,79:208-213.
7DeMario MD, Liebowitz DN. Lymphomas in the immunocompromised patient. Semin Oncol, 1998,25:492-502.
8Hammond CJ, Evans JA, Shah SM, et al. The spectrum of eye disease in children with AIDS due to vertically transmitted HIV disease: clinical findings, virology and recommendations for surveillance. Graefes Arch Clin Exp Ophthalmol,1997,235:125-129.
9Biswas J, Kumar AA, George AE, et al. Ocular and systemic lesions in children with HIV. Indian J Pediatr, 2000,67:721-724.
10Vrabec TR. Posterior segment manifestations of HIV/AIDS. Surv Ophthalmol, 2004,49:131-157.
6Mansour AM, Saad AJ, Haque AK, et al. Ocular pathology in acquired immunodeficiency syndrome [J]. Ann Ophthalmol, 2002, 34 (2): 137-141.
7Skiest DJ, Chiller T, Chiller K, et al. Protease inh-ibitor therapy is associated with markedly prolongedtime to relapse and im provod survival in AIDS patients with cytomegalovirus retinitis [J]. Int J STD AIDS, 2001, 12: 659-664.
